Therapy-related myeloid neoplasms after cytotoxic treatmentResearch Project | 01.04.2023 - 30.09.2023 No Description availableFundingTherapy-related myeloid neoplasms after cytotoxic treatmentSPHN Demonstrator Projects 2022 (GrantsTool), 04.2023-09.2023 (6) PI : Passweg, Jakob R..CI : Kasenda, Benjamin.Members (2) Jakob R. PasswegPrincipal Investigator Benjamin KasendaCo-InvestigatorResearch Groups Research Group Matthias Briel Research Group Jakob Passweg Hämatologie (Passweg)
Therapy-related myeloid neoplasms after cytotoxic treatmentResearch Project | 01.04.2023 - 30.09.2023
FundingTherapy-related myeloid neoplasms after cytotoxic treatmentSPHN Demonstrator Projects 2022 (GrantsTool), 04.2023-09.2023 (6) PI : Passweg, Jakob R..CI : Kasenda, Benjamin.
Therapy-related myeloid neoplasms after cytotoxic treatmentSPHN Demonstrator Projects 2022 (GrantsTool), 04.2023-09.2023 (6) PI : Passweg, Jakob R..CI : Kasenda, Benjamin.